Lite Strategy, Inc. (LITS)
NASDAQ: LITS · Real-Time Price · USD
2.500
+0.050 (2.04%)
At close: Oct 8, 2025, 4:00 PM EDT
2.540
+0.040 (1.60%)
After-hours: Oct 8, 2025, 5:38 PM EDT
Lite Strategy Market Cap
Lite Strategy has a market cap or net worth of $89.49 million as of October 8, 2025. Its market cap has increased by 349.72% in one year.
Market Cap
89.49M
Enterprise Value
67.20M
1-Year Change
349.72%
Ranking
Category
Stock Price
$2.50
Market Cap Chart
Since December 18, 2003, Lite Strategy's market cap has decreased from $424.10M to $89.49M, a decrease of -78.90%. That is a compound annual growth rate of -6.88%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 7, 2025 | 87.40M | 432.93% |
Dec 31, 2024 | 16.40M | -57.51% |
Dec 29, 2023 | 38.60M | 18.77% |
Dec 30, 2022 | 32.50M | -89.20% |
Dec 31, 2021 | 301.00M | 1.31% |
Dec 31, 2020 | 297.10M | 62.62% |
Dec 31, 2019 | 182.70M | -2.72% |
Dec 31, 2018 | 187.80M | 141.70% |
Dec 29, 2017 | 77.70M | 46.60% |
Dec 30, 2016 | 53.00M | -2.93% |
Dec 31, 2015 | 54.60M | -40.85% |
Dec 31, 2014 | 92.30M | -46.40% |
Dec 31, 2013 | 172.20M | 580.63% |
Dec 31, 2012 | 25.30M | 105.69% |
Dec 30, 2011 | 12.30M | 73.24% |
Dec 31, 2010 | 7.10M | -86.19% |
Dec 31, 2009 | 51.40M | - |
Dec 31, 2008 | 51.40M | -74.17% |
Dec 31, 2007 | 199.00M | 2.58% |
Dec 29, 2006 | 194.00M | -45.49% |
Dec 30, 2005 | 355.90M | -30.12% |
Dec 31, 2004 | 509.30M | -23.48% |
Dec 31, 2003 | 665.60M | 56.94% |
Dec 18, 2003 | 424.10M | - |
View and export this data all the way back to 2003. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 753.98B |
Johnson & Johnson | 454.31B |
AbbVie | 413.22B |
UnitedHealth Group | 326.22B |
Novo Nordisk | 264.73B |
AstraZeneca | 264.35B |
Novartis AG | 256.18B |
Abbott Laboratories | 234.25B |